Rocket One Inc. Stock Issued During Period, Value, Conversion of Units
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Rocket One Inc. stock issued during period, value, conversion of units for the quarter ending 2018-12-31 was $0.00.
- Rocket One Inc. stock issued during period, value, conversion of units for the quarter ending 2018-09-30 was $0.00.
- Rocket One Inc. stock issued during period, value, conversion of units for the quarter ending 2018-06-30 was -$1.00.
- Rocket One Inc. stock issued during period, value, conversion of units for the quarter ending 2018-03-31 was $1.02M.
- Rocket One Inc. stock issued during period, value, conversion of units for fiscal 2022 was -$10.00.
- Rocket One Inc. stock issued during period, value, conversion of units for fiscal 2018 was $1.02M.
| Period end | Stock Issued During Period, Value, Conversion of Units 3 month | Stock Issued During Period, Value, Conversion of Units 12 month |
|---|---|---|
| 2022-12-31 | -$10.00 10-K · filed 2023-03-31 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $1.02M 10-K · filed 2020-03-02 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | |
| 2018-06-30 | -$1.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | |
| 2018-03-31 | $1.02M 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |